NORTH AMERICA PROTEIN SEQUENCING MARKET FORECAST 2020-2028

NORTH AMERICA PROTEIN SEQUENCING MARKET FORECAST 2020-2028

The North America protein sequencing market is estimated to record a CAGR of 5.66% during the estimated period of 2020-2028. Due to technological developments in sequencing platforms and an increase in applications of protein sequencing in the region, North America is the dominating contributor to the global protein sequencing market in terms of revenue. In order to further understand the protein sequencing market growth of North America, the region is segregated into the US and Canada. In 2018, the US was the major contributor to the growth of the market. Most global manufacturers of protein sequencing systems, equipment, platform, and technologies are active in the US.

The North America protein sequencing market is estimated to record a CAGR of 5.66% during the estimated period of 2020-2028. Due to technological developments in sequencing platforms and an increase in applications of protein sequencing in the region, North America is the dominating contributor to the global protein sequencing market in terms of revenue.

In order to further understand the protein sequencing market growth of North America, the region is segregated into the US and Canada. In 2018, the US was the major contributor to the growth of the market. Most global manufacturers of protein sequencing systems, equipment, platform, and technologies are active in the US. Most protein sequencing products and platforms are first launched in the US and then throughout the world. Owing to awareness regarding NGS (Next-Generation Sequencing), its application in different fields such as agri-genomics, personalized medicines, and clinical diseases, this region accounts for a major share in the global market. The US market is witnessing steady growth due to the developments in the biotechnology sector. The US-based Swift Biosciences is a biotechnology research company that specializes in manufacturing reagents and kits employed in sample preparation for NGS. Moreover, biosimilars are increasing competition for innovator biologics, including some of the most lucrative franchises of the biotech industry. Furthermore, favorable reimbursement policies also help in increasing the use of dialysis, thereby contributing to market growth of the region.

Agilent Technologies Inc, headquartered in Santa Clara, California, the US, offers instruments, services, software, and consumables solutions to analyze, identify, and quantify the physical and biological properties of substances and products. In 2019, the company announced its complete acquisition of BioTek Instruments, a global leader in the design, manufacture, and distribution of innovative life science instrumentation.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.